Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients

Mehdi Brahmi(Centre Léon Bérard), P. Combemale(Centre Léon Bérard), Jean‐Yves Blay(Université Claude Bernard Lyon 1), Dominique Ranchère(Centre Léon Bérard), S. Pinson(Hôpital Edouard Herriot), Thomas Mognetti(Centre de Recherche en Cancérologie de Lyon), Philippe Thiesse(Institut Gustave Roussy), Anne‐Valérie Decouvelaere(Centre Léon Bérard), Caroline Renard(Centre Léon Bérard)
PLoS ONE
October 7, 2015
10.1371/journal.pone.0138386
Cited by 52

Related Papers

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
|The Lancet|2012|1.4k
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
|The Lancet Oncology|2014|1.2k
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978